Irinotecan, docetaxel and oxaliplatin combination in metastatic gastric or gastroesophageal junction adenocarcinoma

Por Di Lauro, L, Nunziata, C, Arena, M G, Foggi, P, Sperduti, I, Lopez, M
Publicado em 2007

A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients

Por Garufi, C, Bria, E, Vanni, B, Zappalà, A M R, Sperduti, I, Terzoli, E
Publicado em 2003

Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer

Por Gamucci, T, D'Ottavio, A M, Magnolfi, E, Barduagni, M, Vaccaro, A, Sperduti, I, Moscetti, L, Belli, F, Meliffi, L
Publicado em 2007

Optimal tolerability and high efficacy of a modified schedule of lapatinib–capecitabine in advanced breast cancer patients

Por Gamucci, T., Moscetti, L., Mentuccia, L., Pizzuti, L., Mauri, M., Zampa, G., Pavese, I., Sperduti, I., Vaccaro, A., Vici, P.
Publicado em 2013

P08.65 Evaluation of Clinical Benefit in patients treated with Bevacizumab

Por Villani, V., Fabi, A., Lombardi, G., Bellu, L., Zagonel, V., Carapella, C. M., Sperduti, I., Vidiri, A., Pace, A.
Publicado no Neuro Oncol (2016)

Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial

Por Garufi, C, Torsello, A, Tumolo, S, Ettorre, G M, Zeuli, M, Campanella, C, Vennarecci, G, Mottolese, M, Sperduti, I, Cognetti, F
Publicado em 2010

Italian cross-cultural adaptation and validation of three different scales for the evaluation of shoulder pain and dysfunction after neck dissection: University of California - Los...

Por MARCHESE, C., CRISTALLI, G., PICHI, B., MANCIOCCO, V., MERCANTE, G., PELLINI, R., MARCHESI, P., SPERDUTI, I., RUSCITO, P., SPRIANO, G.
Publicado em 2012

Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysis

Por Bria, E., Milella, M., Cuppone, F., Novello, S., Ceribelli, A., Vaccaro, V., Sperduti, I., Gelibter, A., Scagliotti, G. V., Cognetti, F., Giannarelli, D.
Publicado em 2011

Predictive factors for postoperative wound complications after neck dissection

Por PELLINI, R., MERCANTE, G., MARCHESE, C., TERENZI, V., SPERDUTI, I., MANCIOCCO, V., RUSCITO, P., CRISTALLI, G., MARCHESI, P., PICHI, B., SPRIANO, G.
Publicado em 2013

Inflammatory cytokines and biofilm production sustain Staphylococcus aureus outgrowth and persistence: a pivotal interplay in the pathogenesis of Atopic Dermatitis

Por Di Domenico, E. G., Cavallo, I., Bordignon, V., Prignano, G., Sperduti, I., Gurtner, A., Trento, E., Toma, L., Pimpinelli, F., Capitanio, B., Ensoli, F.
Publicado no Sci Rep (2018)

Status of the p53, p16, RB1, and HER-2 genes and chromosomes 3, 7, 9, and 17 in advanced bladder cancer: correlation with adjacent mucosa and pathological parameters

Por Gallucci, M, Guadagni, F, Marzano, R, Leonardo, C, Merola, R, Sentinelli, S, Ruggeri, E M, Cantiani, R, Sperduti, I, Lopez, F de la I, Cianciulli, A M
Publicado em 2005

Recurrence risk in small, node-negative, early breast cancer: a multicenter retrospective analysis

Por Gamucci, T., Vaccaro, A., Ciancola, F., Pizzuti, L., Sperduti, I., Moscetti, L., Longo, F., Fabbri, M. A., Giampaolo, M. A., Mentuccia, L., Di Lauro, L., Vici, P.
Publicado em 2013

ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations

Por Peretti, U., Ferrara, R., Pilotto, S., Kinspergher, S., Caccese, M., Santo, A., Brunelli, M., Caliò, A., Carbognin, L., Sperduti, I., Garassino, M., Chilosi, M., Scarpa, A., Tortora, G., Bria, E.
Publicado no Respir Res (2016)

Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patients

Por Ganci, F., Sacconi, A., Bossel Ben-Moshe, N., Manciocco, V., Sperduti, I., Strigari, L., Covello, R., Benevolo, M., Pescarmona, E., Domany, E., Muti, P., Strano, S., Spriano, G., Fontemaggi, G., Blandino, G.
Publicado em 2013

Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis

Por Bria, E., Pilotto, S., Simbolo, M., Fassan, M., de Manzoni, G., Carbognin, L., Sperduti, I., Brunelli, M., Cataldo, I., Tomezzoli, A., Mafficini, A., Turri, G., Karachaliou, N., Rosell, R., Tortora, G., Scarpa, A.
Publicado no Sci Rep (2016)

Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases

Por Cosimelli, M, Golfieri, R, Cagol, P P, Carpanese, L, Sciuto, R, Maini, C L, Mancini, R, Sperduti, I, Pizzi, G, Diodoro, M G, Perrone, M, Giampalma, E, Angelelli, B, Fiore, F, Lastoria, S, Bacchetti, S, Gasperini, D, Geatti, O, Izzo, F
Publicado em 2010